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Abstract	
	
Background	
Physical	wellbeing	is	commonly	impaired	in	people	with	multiple	sclerosis	
(PwMS).	This	study	aims	to	update	our	previous	systematic	review	(2014)	and	
conduct	a	meta-analysis	on	the	efficacy	of	Mindfulness-based	interventions	
(MBIs)	for	improving	physical	symptoms	in	PwMS.	
	
Methods	
In	November	2017	we	carried	out	systematic	searches	for	eligible	randomised	
controlled	trials	(RCTs)	in	seven	major	databases,	updating	our	search	in	July	
2018.	We	used	medical	subject	headings	and	key	words.	Two	independent	
reviewers	used	pre-defined	criteria	to	screen,	data	extract,	quality	appraise,	and	
analyse	studies.	The	Cochrane	Collaboration	risk	of	bias	tool	was	used	to	
determine	study	quality.	Physical	wellbeing	was	the	main	outcome	of	interest.	
We	used	the	random	effects	model	for	meta-analysis,	reporting	effect	sizes	as	
Standardised	Mean	Difference	(SMD).	This	study	is	registered	with	PROSPERO:	
CRD42018093171.	
	
Results	
We	identified	10	RCTs	as	eligible	for	inclusion	in	the	systematic	review	
(including	678	PwMS),	whilst	seven	RCTs	(555	PwMS)	had	data	that	could	be	
used	in	our	meta-analyses.	In	general,	comorbidity,	disability,	ethnicity	and	
socio-economic	status	were	poorly	reported.	MBIs	included	manualised	and	
tailored	interventions,	treatment	duration	6-9	weeks,	delivered	face-to-face	and	
online	in	groups	and	also	individually.	For	fatigue,	against	any	comparator	SMD	
was	0.24	(0.08	–	0.41),	I2=0%;	against	active	comparators	only,	SMD	was	0.10	(-
0.14	–	0.34),	I2=0%.	For	pain	SMD	was	0.16	(-0.46	–	0.79),	I2=77%.	Three	adverse	
events	occurred	across	all	studies.	
	
Conclusions	
MBIs	appear	to	be	an	effective	treatment	for	fatigue	in	PwMS.	The	optimal	MBI	in	
this	context	remains	unclear.	Further	research	into	MBI	optimisation,	cost-	and	
comparative-effectiveness	is	required.	
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1.1	Background	
Multiple	sclerosis	(MS)	is	a	complex,	poorly	understood	chronic	inflammatory	
and	neurodegenerative	condition	1.	Common	physical	symptoms	include	
difficulties	with	vision,	speech,	swallow,	bowel,	bladder	and	sexual	function,	
chronic	pain,	spasticity	and	limited	mobility	1.	Comorbidity,	or	the	presence	of	an	
additional	long-term	condition	besides	MS,	is	common	among	people	with	
multiple	sclerosis	(PwMS)	2.	Physical	comorbidities	in	MS	are	associated	with	
more	CNS	lesions	on	Magnetic	Resonance	Imaging	(MRI),	greater	levels	of	
disability,	increased	hospitalisations,	and	higher	mortality	rates	3.	Furthermore,	
having	additional	physical	conditions	in	MS	is	associated	with	more	stress	and	
worse	quality	of	life	(QoL);	as	the	number	of	additional	physical	conditions	
increase,	so	does	the	prevalence	of	mental	health	impairment	2.		
	
Among	physical	comorbidities	in	PwMS,	hypertension,	hyperlipidaemia	and	
chronic	lung	disease	predominate	4.	Specific	care	guidelines	for	managing	these	
physical	comorbidities	in	PwMS	do	not	exist	3.	Fatigue	and	chronic	pain	are	
among	the	commonest	symptoms	reported	by	PwMS	5	6.	The	UK	National	
Institute	for	Care	and	Clinical	Excellence	(NICE)	recommends	offering	PwMS	
cognitive	behavioural	therapy	(CBT),	aerobic	exercise,	yoga,	or	amantadine	for	
fatigue,	as	well	as	avoiding	stress	and	treating	comorbid	anxiety	and	depression	
7.	For	chronic	pain	in	PwMS,	NICE	recommends	the	application	of	generic	
treatment	approaches	7.	
	
Mindfulness-based	interventions	(MBIs)	fit	the	UK	Medical	Research	Council	
criteria	for	complex	interventions	8,	with	multiple	potential	active	components.	
Originally	introduced	in	North	America	in	the	1980s	as	a	treatment	for	people	
with	chronic	pain	9,	MBIs	characteristically	include	a	range	of	meditation	
practices,	group	exercises,	psychoeducation	and	home	practices	10	11.	MBIs	have	
been	applied	and	researched	in	a	range	of	health	conditions	and	found	to	be	
effective	treatments	for	anxiety,	stress,	recurrent	depression	and	somatisation	
disorders	12	13.	In	a	previous	systematic	review	of	the	effectiveness	of	MBIs	in	
PwMS	in	2014	14	we	found	limited	evidence	from	two	randomised	controlled	
trials	(RCTs)	and	a	controlled	trial	to	support	MBIs	as	a	potential	treatment	for	
comorbid	fatigue	and	comorbid	pain	in	the	condition,	as	well	as	improving	
standing	balance	14.	Since	2014,	several	more	RCTs	have	been	published	and	it	is	
important	to	determine	more	definitively	whether	MBIs	are	effective	treatments	
for	fatigue	and	pain	in	PwMS,	besides	other	commonly	encountered	physical	
symptoms.			
	
The	aim	of	this	review	is	to	conduct	a	meta-analysis	of	RCTs	testing	the	efficacy	
of	MBIs	in	improving	physical	symptoms	in	PwMS.		
	
2.1	Methods	
2.2	Protocol	and	registration	
Our	protocol	was	registered	prospectively	with	the	Centre	for	Reviews	and	
Dissemination,	University	of	York,	Prospero	ID:	CRD42018093171.	This	body	of	
work	also	included	a	meta-analysis	of	MBI	effects	on	mental	wellbeing	in	PwMS,	
reported	separately	15.	
	
2.3	Eligibility	for	inclusion	
We	based	eligibility	on	the	Study	design,	Participants,	Interventions,	Outcomes	
(SPIO)	model	(deriving	from	PICOS)	16.	To	be	eligible	for	inclusion,	studies	had	to	
be	RCTs,	(comparing	MBI	vs	active	comparator	or	care	as	usual),	with	no	limit	
placed	on	sample	size.	Participants	had	to	be	PwMS	(of	any	phenotype),	aged	18	
years	or	older.	The	intervention(s)	being	tested	had	to	be	a	recognisable	MBI	
that	included	core	practices	of	mindful	breathing,	mindful	body	awareness,	and	
mindful	movement;	Mindfulness-based	stress	reduction	(MBSR)	and	
Mindfulness-based	cognitive	therapy	(MBCT)	served	as	reference	guides	in	this	
regard.	Outcomes	had	to	be	appropriately	validated	and	report	on	a	definable	
aspect	of	physical	wellbeing	experienced	by	PwMS	(e.g.	symptoms	such	as	
fatigue,	pain,	standing	balance).		
	
2.4	Search	strategy	
We	employed	a	search	strategy	from	our	previous	systematic	review	for	use	in:	
Allied	and	Complementary	Medicines	Database	(AMED),	Cochrane	Central	
Register	of	Controlled	Trials,	Cumulative	Index	of	Nursing	and	Allied	Health	
Literature	(CINAHL),	Excerpta	Medica	dataBASE	(EMBASE),	Medical	Literature	
Analysis	and	Retrieval	System	Online	(MEDLINE),	and	PsycINFO.	As	our	previous	
systematic	review	found	the	first	study	in	this	area	was	published	in	2000,	we	
set	our	‘years’	delimiter	to	2000	–	2018.	In	addition,	we	also	searched	ProQuest	
Dissertations	&	Theses,	reviewed	key	references	from	identified	studies,	
searched	the	grey	literature,	and	approached	experts	in	the	field.	We	carried	out	
our	initial	search	in	November	2017	and	repeated	this	in	July	2018.	Our	search	
strategy	as	used	in	MEDLINE	is	available	in	Appendix	A.	
	
2.5	Study	selection,	storage	and	screening	
We	imported	search	results	into	COVIDENCE,	a	data	storage	package	for	
systematic	reviews.	Title/abstracts	were	screened	by	two	reviewers	(RS,	SS)	for	
potential	eligibility	using	keywords	like	‘mindfulness’	and	‘multiple	sclerosis’.	
Selected	studies	were	then	assessed	against	SPIO	criteria	by	two	reviewers	(JB,	
RS)	to	assess	ultimate	eligibility.	A	senior,	third	party	reviewer	(SM)	was	
available	to	arbitrate	any	disagreements.		
	
2.6	Data	collection/data	items	
Data	from	the	final	list	of	included	studies	was	extracted	guided	by	CONSORT	17	
and	TIDieR	18	checklist	categories	(Appendix	B).	
	
2.7	Quality	appraisal	
We	used	the	Cochrane	Collaboration’s	tool	for	assessing	risk	of	bias	(RoB)	19	to	
summarise	risk	for	individual	outcomes	in	selected	studies,	graded	as	high,	
unclear,	or	low	risk.	This	assessed	generation	of	sequence,	concealment	of	
allocation,	blinding	of	participants,	outcome	assessors	and	personnel,	incomplete	
outcomes,	selective	reporting	of	outcomes,	and	any	other	bias.	Finally,	as	
outlined	by	Higgins	et	al.	(2011)19,	an	overall	RoB	within	each	trial	was	
determined	based	on	the	number	of	individual	outcomes	falling	in	to	the	high,	
unclear,	and	low	risk	categories:		
Low	=	Low	RoB	for	all	key	domains		
Unclear	=	Low	or	unclear	RoB	for	all	key	domains		
High	=	High	RoB	for	one	or	more	key	domains		
	
2.8	Principal	summary	measures	
The	main	outcome	for	this	study	was	impact	of	MBI	on	physical	symptoms.	Main	
outcome	measures	were	all	reported	as	continuous	with	mean,	standard	
deviation	(SD)	values	and	the	number	of	participants	for	each	treatment	group	
extracted.	“Effect	size”	is	reported	as	the	unbiased	standardised	mean	difference	
(SMD),	a	positive	SMD	indicating	a	finding	in	support	of	the	intervention	having	a	
positive	treatment	effect	(TE).	The	standardised	mean	difference	was	calculated	
by	difference	in	means	between	the	MBI	and	the	control	group	at	last	point	of	
follow-up	divided	by	the	pooled	last	point	of	follow-up	SD.		Where	effect	
estimates	were	reported	from	adjusted	regression	models,	we	extracted	these	as	
the	SMD	with	their	corresponding	SD.		
	
2.9	Synthesis	of	results	
Throughout	this	study	we	adhered	to	the	Preferred	Reporting	Items	for	
Systematic	Reviews	and	Meta-Analyses	(PRISMA)	20	guidance.	We	used	a	
random-effects	meta-analysis,	with	an	inverse	variance	method	for	pooling	21	to	
determine	SMD,	as	outcome	measures	were	known	to	vary	widely.	We	report	
estimates	with	corresponding	95%	confidence	intervals	(CI)	and	‘p’	values.	We	
used	the	I2	statistic	to	determine	variability	between	studies	22;	I2	representing	
the	percentage	of	total	variability	in	effect	size	estimates	due	to	heterogeneity.	
An	I2	of	0%	indicates	that	all	heterogeneity	is	consistent	with	sampling	error,	
whilst	an	I2	of	100%	suggests	all	variability	may	be	attributable	to	studies	being	
truly	heterogenous.			
	
To	assess	for	evidence	of	publication	bias,	we	undertook	Funnel	plots	and	
Egger’s	Test	for	asymmetry	23	24.		
	
We	carried	out	all	statistical	analyses	in	R	version	3.4.0	and	using	the	meta	
package	25.			
	
3.1	Results	
We	identified	ten	RCTs	as	eligible	for	inclusion	in	the	systematic	review,	with	
seven	studies	reporting	endpoint	data	usable	in	meta-analysis	(Figure	1).	We	
sought	additional	information	from	several	study	authors;	one	26	replied.	
	
Figure	1	–	PRISMA	flow	diagram	
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3.2	Systematic	review	
3.2.1	Study	characteristics	
Three	studies	took	place	in	Iran	27-29,	three	in	the	UK	30-32,	two	in	Italy	26	33,	one	
each	in	the	USA	34	and	Switzerland	35.	Four	studies	tested	a	MBI	against	
treatment	as	usual	30-32	35,	four	versus	an	active	comparator	(three	a	psycho-
education	control	26	33	34,	one	pelvic	floor	muscle	exercises	29),	and	in	two	the	
control	condition	was	not	clearly	specified	27	28.	Four	study	sample	sizes	were	
based	on	statistical	power	calculations	26	33-35.	Number	of	study	participants	
ranged	from	24	–	150	(median	62).	Eight	studies	reported	measuring	outcomes	
at	three	points	in	time	(baseline,	immediately	post	MBI,	and	at	further	follow-up,	
which	varied	from	1	month	post	MBI	to	1	year	later)	26	29-35,	whilst	two	studies	
took	measures	twice,	pre	and	post	MBI	27	28	(Table	1).
Table	1-	Study	characteristics	
Study		 Country	 Study	
design		
Powered	
(Y/N/	
unclear)	
Comparator	 Sample	
size		
(n)	
Study	
attrition	
(%)	
Outcome	measures	(others)	 Data	collection	
Mills	&	Allen	
(2000)	 Wales	(UK)	
Randomised	
controlled	
trial	
N	 Treatment	as	usual	 24	 33	 Profile	of	Mood	States,	Standing	balance,	Symptom	rating	questionnaire	
o Baseline	
o Post	MBI	
o 3	months	post	MBI	
Grossman	et	
al.	(2010)		 Switzerland	
Randomised	
controlled	
trial	 Y	
Treatment	as	
usual	 150	 5	
Center	for	Epidemiological	Studies	Depression,	Spielberger	Trait	Anxiety	
Inventory,	Modified	Fatigue	Impact	Scale,	Hamburg	Quality	of	life	
Questionnaire	in	Multiple	Sclerosis,	Profile	of	health-related	Quality	Of	
Life	in	Chronic	disorders,	Goal	setting,	Neuropsychology	assessment		
o Baseline	
o Post	MBI	
o 6	months	post	MBI	
Bogosian	et	al.	
(2015)		 England	
(UK)	
Randomised	
controlled	
trial	
N	 Treatment	as	usual	 40	 5	
General	Health	Questionnaire,	Hospital	Anxiety	and	Depression	Scale,	
Multiple	Sclerosis	Impact	Scale-29,	EuroQol,	Fatigue	Severity	Scale,	
Numerical	Rating	Scale	(Pain)	
o Baseline	
o Post	MBI	
o 3	months	post	MBI	
Mahdavi	et	al.	
(2016)		 Iran	
Randomised	
controlled	
trial	
N	 Indeterminate	 24	 0	 Beck	Anxiety	Inventory,	Beck	Depression	Inventory,	Fatigue	Severity	Scale,	Meta-Worry	Questionnaire,	Thought	Fusion	Inventory	
o Baseline	
o Post	MBI	
Nejati	et	al.	
(2016)		 Iran	
Randomised	
controlled	
trial	
Unclear	 Indeterminate	 24	 0	 Multiple	Sclerosis	Quality	of	Life-54,	Fatigue	Severity	Scale	 o Baseline	o Post	MBI	
Simpson	et	al.	
(2017)		
Scotland	
(UK)	
Randomised	
controlled	
trial	
N	 Treatment	as	usual	 50	 12	
Perceived	Stress	Scale,	EuroQol,	Multiple	Sclerosis	Quality	of	Life	
Inventory,	Mindful	Attention	Awareness	Scale,	Self-Compassion	Scale-
short	form,	Emotional	Lability	Questionnaire	
o Baseline	
o Post	MBI	
o 3	months	post	MBI	
Carletto	et	al.	
(2017)		 Italy	
Randomised	
controlled	
trial	
Y	 Psycho-education		 90	 21	
Beck	Anxiety	Inventory,	Beck	Depression	Inventory,	Perceived	Stress	
Scale,	Brief	Illness	Perception	Questionnaire,	Functional	Assessment	of	
Multiple	Sclerosis,	Fatigue	Severity	Scale	
o Baseline	
o Post	MBI	
o 6	months	post	MBI	
Cavalera	et	al.	
(2018)	
	
Italy	
Randomised	
controlled	
trial	
Y	 Psycho-education		 139	 39	
Multiple	Sclerosis	Quality	of	Life-54,	Hospital	Anxiety	and	Depression	
Scale,	Medical	Outcomes	Sleep	Scale,	Modified	Fatigue	Impact	Scale	
o Baseline	
o Post	MBI	
o 6	months	post	MBI	
Mosalanejad	
et	al.	(2018)		 Iran	
Randomised	
controlled	
trial	
Unclear	 Pelvic	floor	muscle	exercises	 75	 7	 Female	Sexual	Function	Index	
o Baseline	
o Post	MBI	
o 1-month	post	MBI	
Senders	et	al.	
(2018)		
USA	
Randomised	
controlled	
trial	 Y	 Psycho-education	 62	 16	
Perceived	Stress	Scale,	Patient-Reported	Outcomes	Information	System,	
Connor-Davidson	Resilience	Scale,	Paced	Auditory	Serial	Attention	Task	
o Baseline		
o Mid-intervention		
o Post	MBI		
o 4	months	post	MBI	
o 8	months	post	MBI	
o 12	months	post-MBI	
3.2.2	Participant	characteristics	
There	were	678	participants	between	the	10	RCTs	included	in	the	systematic	
review,	versus	555	participants	in	the	seven	studies	included	in	the	meta-
analysis.	Participant	ethnicity	was	described	in	three	studies	30	32	34,	most	were	
Caucasian.	Between	all	10	RCTs,	the	majority	were	female	(76%;	n=517).	The	
extractable	mean	participant	age	was	46.0	years	(not	reported	in	27).	One	study	
reported	on	socioeconomic	status	(SES)	using	post-code	derived	data	32.	Three	
studies	described	negligible	data	on	employment	status	of	participants	31-33.	
Seven	studies	reported	education	status	26-28	30	32	34	35,	most	having	school	level	
education	as	a	minimum.	The	majority	(a	minimum	of	414	or	61%)	had	a	
relapsing-remitting	phenotype,	a	minimum	of	112	(17%)	a	secondary	
progressive	phenotype,	and	a	minimum	of	27	(4%)	had	a	primary	progressive	
phenotype.	Degree	of	disability	was	reported	in	five	studies	30	32-35,	using	the	
Expanded	Disability	Status	Scale	(EDSS)	with	a	range	of	2.3	–	6.5.	Comorbidity	
(mental	and	physical)	count	was	described	in	one	study	32	(mean	2.3,	SD	1.7).	
Four	studies	26	32	34	35	described	use	of	psychotropic	and/or	MS	disease	
modifying	drugs	(Table	2).
Table	2	–	Participant	characteristics	
Study/	
demographic	
Mills	&	Allen	
(2000)	
Grossman	et	al.	
(2010)	
Bogosian	et	al.	
(2015)	
Mahdavi	et	
al.	(2016)	
Nejati	et	al.	
(2016)	
Simpson	et	al.	
(2017)	
Carletto	et	al.	
(2017)	
Cavalera	et	al.	
(2018)	
Mosalanejad	et	
al.	(2018)	
Senders	et	al.	
(2018)	
Ethnicity	 Not	reported	 Not	reported	 90%	British	Caucasian	 Not	reported	 Not	reported	
100%	British	
Caucasian	 Not	reported	 Not	reported	 Not	reported	 97%	Caucasian	
Number	of	
participants	(%	F)	 16	(80%)	 150	(80%)	 40	(55%)	 24	(100%)	 24	(46%)	 50	(92%)	 90	(71%)	 139	(65%)	 75	(100%)	 67	(78%)	
Mean	age	(SD)	 49.8	(6.8)	 47.3	(10.3)	 52.2	(9.1)	 NR	 32.3	(5.1)	 45	(10.9)	 44.6	(9.4)	 42.7	(8.7)	 37.5	(6.5)	 52.94	(11.37)	
Socio-economic	
status	 Not	reported	 Not	reported	 Not	reported	 Not	reported	 Not	reported	
Postcode	derived;	
controlled	in	
analyses	
Not	reported	 Not	reported	 Not	reported	 Not	reported	
Employment	
status	
4	employed	
(25%)	 Not	reported	 Not	reported	 Not	reported	 Not	reported	
20	employed	
(40%)	
59	employed	
(65%)	 Not	reported	 Not	reported	 Not	reported	
Education	status	
(SD)	 Not	reported	
Mean	(SD)	14.1	
(1.9)	years	of	
education	
31	(77.5)	college	
education	at	least	
Completed	
high	school	
Completed	
high	school	 (56%)	university		 Not	reported	
11%	elementary	
school;		
52%	completed	high	
school;	
38%	university	
Not	reported	 60%	college	education	at	least	
Disease	
phenotype	(%)	
Secondary	
progressive	16	
(100%)	
Relapsing	123	
(82%)	
	
Secondary	
progressive	27	
(18%)	
Secondary	
progressive	23	
(57.5%)	
	
Primary	
progressive	17	
(42.5%)	
Not	reported	 Not	reported	
Relapsing	40	
(80%)	
	
Secondary	
progressive	16	
(32%)	
	
Primary	
progressive	4	(8%)	
Relapsing	79	
(88%)	
	
Secondary	
progressive	7	
(8%)	
	
Primary	
progressive	2	
(2%)	
Relapsing	131	
(93%)	
	
Secondary	
progressive	8	(7%)	
Not	reported	
Relapsing	41	
(67%)	
	
Secondary	
progressive	15	
(25%)	
	
Primary	
progressive	4	
(6%)	
	
Unknown	2	(3%)	
EDSS	score	 Not	reported	 Mean	(SD)	3.0	(1.1)	 Mean	(SD)	6.5	(1.5)	 Not	reported	 Not	reported	 4.4	(1.8)	 2.3	(1.7)	 Median	3.0	 Not	reported	 4.6	(1.93)	
Comorbidities	 Not	reported	 Not	reported	 Not	reported	 Not	reported	 Not	reported	 Mean	2.4	(2.0);	Range	0-9	 Not	reported	
1	participant	had	
severe	depression	
on	HADS	
Excluded	if	
comorbid	
conditions	
Not	reported	
On	DMDs	 Not	reported	 91	(60.1%)	 Not	reported	 Not	reported	 Not	reported	 26	(52%)	 Not	reported	 104	(85%)	 Not	reported	 34	(55%)	
Psychotropic	
medication(s)	 Not	reported	 30	(20%)	 Not	reported	 Not	reported	 No	 23	(46%)	 Not	reported	 9	(6%)	 Not	reported	 35	(56%)	
3.2.3	Intervention	characteristics	
MBSR	was	explicitly	used	as	the	MBI	in	four	studies	26	32	34	35	and	the	loose	basis	
in	a	further	two		28	33,	two	explicitly	used	MBCT	27	30,	one	described	the	
intervention	as	‘Mindfulness	of	Movement’	31,	and	in	the	remaining	case	the	
foundation	for	the	MBI	was	unclear	29.		Five	studies	reported	on	what	course	
materials	were	provided	to	those	taking	part	26	28	30-32.	An	interview	was	
compulsory	prior	to	taking	part	in	three	studies	27	28	35.	Two	studies	required	
evidence	of	impaired	mental	wellbeing	(stress,	anxiety)	at	baseline	in	order	to	
take	part	30	34.	Six	studies	reported	on	what	MBI	sessions	comprised	27	28	30	32	34,	
three	provided	scant	information	in	this	regard	31	33	35,	and	in	another	this	
information	was	available	in	a	separate	publication,	via	the	study	protocol	26.	
Home	practices	were	prescribed	in	six	studies	30-35.	Teacher	characteristics	
(training/certification/experience)	were	outlined	in	seven	studies	26	29	30	32-35,	
but	details	were	sparse	in	one	29.	MBIs	were	delivered	as	groups	in	nine	studies	
26-30	32-35,	the	remaining	study	delivered	a	one-to-one	MBI31.	An	online	platform	
was	used	to	deliver	the	MBI	in	two	studies	26	30.	Four	studies	reported	where	the	
MBI	took	place	26	29	30	32.	The	majority	of	studies	used	eight	MBI	sessions	26-30	32-
34,	there	were	nine	in	one	study	35,	another	used	six	31.	Weekly	MBI	session	
lengths	varied	between	1-3	hours.	There	were	between	five	to	25	participants	
per	MBI	class	across	the	studies,	sessions	being	administered	by	1-2	MBI	
instructors.	The	core	MBI	components	were	delivered	in	all	studies.	However,	in	
six	studies	the	MBI	was	tailored	for	PwMS	26	30-33	35,	mostly	in	advance,	but	
reflexively	in	one	case	32,	where	mindful	movement	was	simplified	to	
accommodate	high	levels	of	disability.	Another	study	pre-emptively	removed	
mindful	movement	following	stakeholder	consultation	30.	Home	practice	
completion	and/or	session	attendance	was	used	to	determine	treatment	
adherence	in	six	studies	26	30-32	34	35.	Intervention	fidelity	was	appraised	in	three	
studies	26	30	32,	in	one	case	by	an	independent	observer	checking	session	content	
against	referenced	standards	30.	The	day	retreat,	characteristically	part	of	week	
six	in	MBSR,	was	included	in	three	studies		33-35	(Table	3	outlines	intervention	
characteristics	using	the	Template	for	Intervention	Description	and	Replication	
checklist).
Table	3	–	Template	for	Intervention	Description	and	Replication	(TIDieR)	checklist	
Study/	
checklist	
item	
Mills	&	
Allen	
2000	
Grossman	
et	al.	2010	
Bogosian	et	
al.	2015	
Mahdavi	et	
al.	2016	
Nejati	et	
al.	2016	
Simpson	
et	al.	2017	
Carletto	et	
al.	2017	
Cavalera	
et	al.	2017	
Mosalanejad	
et	al.	2018	
Senders	
et	al.	2018	
1.	Brief	name?	 Mindfulness	of	
Movement	
Mindfulness-
based	stress	
reduction	
(MBSR)	
Mindfulness-
based	cognitive	
therapy	
Mindfulness-
based	cognitive	
therapy	
MBSR	and	
Conscious	
Yoga	
Mindfulness-
based	stress	
reduction	
Modified	MBSR	–	
‘Body	Affective	
Mindfulness’	
Mindfulness-
based	stress	
reduction	
‘Mindfulness’	 Mindfulness-
based	stress	
reduction	
2.	Why	(stated	
rationale/	
theory/	goal)?	
Develop	
moment	to	
moment	
awareness	of	
breath,	
posture,	
movement	
with	
compassion	
Cultivate	
interested,	
accepting,	non-
judgmental	
attitude	to	
experience,	
including	
difficult	
sensations,	
emotions,	
thoughts	and	
behavior	
Adaptation	of	
MBSR.	Focus	on	
negative	
thinking,	
engaging	low	
mood,	changing	
relationship	
with	thoughts,	
feelings,	
sensations,	no	
longer	avoiding/	
reacting	to	them	
automatically	
		
Adaptation	of	
MBSR.	Focus	on	
negative	
thinking,	
engaging	low	
mood,	changing	
relationship	
with	thoughts,	
feelings,	
sensations,	no	
longer	
avoiding/	
reacting	to	
them	
automatically	
	
Facilitate	the	
compliance	
with	and	
adaptation	to	
medical	
conditions.	
Pay	attention	
to	being	
present	in	a	
non-
judgmental	
manner	
Cultivate	
interested,	
accepting,	
non-
judgmental	
attitude	to	
experience,	
including	
difficult	
sensations,	
emotions,	
thoughts	and	
behavior	
Cultivation	of	
mindful	
awareness,	
loving	kindness,	
enrichment	of	
listening,	self-
compassion,	
sensorimotor	
psychotherapy	
principles	
‘window	of	
tolerance’	
Cultivate	
interested,	
accepting,	
non-
judgmental	
attitude	to	
experience,	
including	
difficult	
sensations,	
emotions,	
thoughts	and	
behavior	
Non-	judgmental	
present	moment	
awareness	
Cultivate	
interested,	
accepting,	
non-
judgmental	
attitude	to	
experience,	
including	
difficult	
sensations,	
emotions,	
thoughts	and	
behavior	
3.	What	-	
Materials	
provided	to	
participants?		
Written	
handout,	audio	
and	video	aids		
	
Not	reported	 Headset,	
webcam,	
compact	discs	
for	home	
practice	
Not	reported	 Leaflets	for	
each	session	
and	compact	
discs	for	
home	
practice		
Course	
manual,	
compact	discs	
for	home	
practice		
Book	-	Full	
Catastrophe	
Living	
Not	reported	 Dedicated	
website	with	
online	
multimedia	for	
home	
practices	
Not	reported	 Not	reported	
4.	What	-	
Procedures	-
Pre-session?		
Had	to	make	a	
commitment	to	
regular	
practice	
Personal	intake	
interview;	goal	
planning	
Screened	for	
evidence	of	
distress	on	
General	Health	
Questionnaire	
Personal	intake	
interview	
Personal	
intake	
interview	
Not	reported	 Not	reported	 Not	reported	 Not	reported	 Score	of	at	
least	1ten	on	
Perceived	
Stress	Scale	
4.	What	-	
Procedures	–	
In	session?	
General	
description	
only	-		
	
Body	
awareness,	
breath	
awareness,	
General	
description	
only	-		
	
Observation	of	
sensory,	
cognitive	and	
affective	
Session	content	
reported	in	
paper	–		
	
Raisin	exercise,	
Mindful	
awareness,	body	
scan,	sitting	
Session	
outline	
reported	in	
paper	–		
	
Sustained	
attentional	
focus	on	the	
Session	
outline	
reported	in	
paper	–		
	
Body	
awareness,	
raisin	
Session	
content	
reported	in	
paper	–		
	
Raisin	
exercise,	
Mindful	
General	
description	in	
trial	protocol	–		
	
Emphasis	on	
sensorimotor	
resources:	
grounding,	
General	
description	
only	-		
	
Based	on	
original	
Mindfulness-
based	stress	
Session	content	
reported	in	paper	
–		
	
Mindful	breathing,	
body	scan,	sitting	
mediation,	
mountain	
Session	
content	
reported	in	
paper	–		
	
Mindful	
breathing,	
body	scan,	
mindful	
movement,	Tui	
Na	self-
massage	
experience	in	
lying,	siting,	and	
dynamic	yoga	
postures	
practice,	three-
minute	
breathing	space,	
psycho-
education,	
cognitive	
exercises	
body	and	
breath,	
decentered	
view	of	
thoughts	as	
passing	mental	
events	
exercise,	
three-minute	
breathing,	
yoga,	sitting	
meditation,	
psycho-
education	on	
stress,	
mountain	
meditation	
breathing,	
body	scan,	
mindful	
movement,	
psycho-
education	
centring,	self-
soothing,	psycho-	
education	on	
stress,	self-
compassion,	
body	scan,	
breath	
meditation,	
walking	
meditation,	yoga	
exercises	
reduction	
protocol	
meditation,	mindful	
eating,	choice-less	
awareness,	loving	
kindness,	psycho-	
education	
mindful	
movement,	
loving	
kindness,	
sitting	
meditation,	
push-	pull	
exercise,	
psycho-	
education	on	
stress	
4.	What	–	
Procedures	-
Home	practice?	
Thirty	minutes	
per	day	
Forty	minutes	
per	day	
Ten-twenty	
minutes	per	day	
Not	reported	 Not	reported	 Forty-five	
minutes	per	
day	
Forty-five	
minutes	per	day	
Not	reported	 Not	reported	 Forty-five	
minutes	per	
day	
4.	What	-	
Procedures	–	
Post-course?	
Not	reported	 Post	course	
interviews	for	
all	participants	
Post	course	
interviews	for	
some	
participants	
Not	reported	 Not	reported	 Post	course	
interviews	for	
some	
participants	
Not	reported	 Not	reported	 Not	reported	 Not	reported	
5.	Who	
provided?	
Not	reported	 Two	
experienced	
(over	nine	
years),	certified	
teachers	
Study	author.	
Had	completed	
MBI	teacher	
training	
Not	reported	 Not	reported	 Two	
experienced	
(seven	and	a	
half	years),	
certified	
physician	
teachers	
Trained	clinical	
psychologists,	
used	to	working	
with	people	with	
multiple	
sclerosis	
Expert	MBSR	
trainer	
Study	author	 Certified	
MBSR	teacher	
with	sixteen	
years	of	
experience	
6.	How	-	Mode	
of	delivery?	
One-to-one,	
face-to-face	
Group,	face-to-
face,	ten-fifteen	
per	group	
Group,	via	
Skype,	up	to	five	
per	group	
Group,	twelve	
per	group	
Group,	
twelve	per	
group	
Group,	face-to-
face,	twenty-
five	per	group	
Group,	number	
per	group	not	
reported	
Group,	via	
Skype,	average	
of	five	per	
group	
Not	reported	 Group,	
number	per	
group	not	
reported	
7.	Where	-	
Intervention	
location?	
Unclear	 Unclear	 Participants’	
own	homes	
Unclear	 Unclear	 NHS	Centre	for	
Integrative	
Care	
Unclear	 In	patients	
own	homes	
University	hospital	
out-	patient	clinic	
Not	reported	
8.	When	and	
how	much?		
Six	weekly	
sessions	
Nine	weekly	
two	and	a	half	
hour	sessions	
	
Seven-hour	
practice	day	at	
week	six	
Eight	weekly	
one	hour	
sessions	
Eight	weekly	
two	hour	
sessions	
Eight	weekly	
two	hour	
sessions	
Eight	weekly	
two	and	a	half	
hour	sessions	
Eight	weekly	
three	hour	
sessions	
	
Seven-hour	
practice	day	
Eight	weekly	
sessions	(?	
duration)	
Eight	weekly	ninety	
minute	sessions	
Eight	weekly	
two	hour	
sessions	
	
Six-hour	
practice	day	at	
week	six	
9.	Tailoring?	 Individualised	
application	of	
core	
techniques	
Exercises	did	
not	exceed	level	
of	function	
Developed	with	
people	with	
multiple	
sclerosis.	MBCT	
manual	adapted	
for	Progressive	
Not	reported	 Not	reported	 Developed	
with	people	
with	multiple	
sclerosis,	
informed	
MBSR	
Protocol	reports	
tailoring	to	needs	
of	participants,	
but	not	reported	
in	paper	
Music	
meditations	
and	
acceptance	of	
multiple	
sclerosis	
Not	reported	 Not	reported	
multiple	
sclerosis	issues		
Mindful-
movement	
removed	
optimisation	
for	future	
iteration	
symptoms	
introduced	
10.	In	study	
modifications?		
Not	reported	 Not	reported	 Not	reported	 Not	reported	 Not	reported	 Mindful	
movement	
simplified	
Not	reported	 Not	reported	 Not	reported	 Not	reported	
11.	How	well	-	
Treatment	
adherence?	
Average	thirty-
two	minutes	
home	practice	
per	day	
Ninety-two	
percent	session	
attendance;		
	
Average	
twenty-nine-
point	two	
minutes	home	
practice	per	day	
Ninety-five	
percent	
completed	four	
or	more	
sessions.		
	
Home	practice	
not	reported	
Not	reported	 Not	reported	 Sixty	percent	
session	
attendance;		
	
Average	
thirty-two	and	
a	half	minutes	
home	practice	
per	day	
Not	reported	 Seventy-nine	
percent	
session	
attendance	
Not	reported	 Eighty-five	
percent	
attended	six	or	
more	sessions.	
	
Median	home	
practices	
thirty-eight	
minutes	per	
day		
12.	How	well	-	
Fidelity	
assessment?	
Not	reported	 Not	reported	 Senior	clinical	
psychologist	
listened	to	
session	
recordings	for	
every	session	
Not	reported	 Not	reported	 Based	on	
National	
Institutes	of	
Health	(2004)		
Not	reported	 Treatment	
integrity	
monitored,	but	
not	reported	
in	what	way	
Not	reported	 Not	reported	
3.2.4	Outcome	characteristics	
Seven	studies	measured	the	impact	of	MBI	on	fatigue	26	28	30	32-35,	three	on	pain	30	
32	34,	one	on	standing	balance	31,	one	on	sleep	26,	and	one	on	female	sexual	
function	29.	As	all	three	studies	that	reported	on	pain	also	reported	on	fatigue,	
fatigue	was	thus	chosen	as	the	main	outcome	for	our	analysis.		
	
Average	home	practice	was	reported	in	three	studies	(32,	29.2,	32.5	minutes)	31	
32	35;	whilst	one	study	reported	median	value/	minimum-maximum	range	(38	
minutes/day;	14	–	80)	34.	Attrition	ranged	from	0-39%	across	the	ten	studies;	
those	with	no	attrition	were	pre-post-	studies	with	small	sample	sizes	27	28.	
	
3.3	Meta-analysis	
3.3.1	Effect	of	MBIs	on	physical	symptom	measures	
The	effect	of	a	MBI	on	physical	symptoms	was	measured	in	10	studies	26-35;	
seven	reported	endpoint	data	usable	in	the	meta-analysis	26	28	30	32-35.	Seven	
studies	evaluated	MBI	effect	on	fatigue	26	28	30	32-35,	where	the	SMD	against	any	
comparator	was	0.24	(0.08	–	0.41)	p<0.01,	I2=0%	(low	heterogeneity)	(Figure	2);	
against	active	comparators	only	the	SMD	for	fatigue	was	0.10	(-0.14	–	0.34),	
p=0.40,	I2=0%	(low	heterogeneity)	(Figure	3).	Three	studies	also	evaluated	MBI	
effect	on	pain	(besides	fatigue)	30	32	34,	where	the	SMD	was	0.16	(-0.46	–	0.79),	
p=0.61,	I2=77%	(substantial	heterogeneity)	(Figure	4).	
	
Figure	2	SMD	for	fatigue	vs	any	comparator	
	
TE	-	Treatment	effect;	seTE	-	standard	error	of	the	TE;	SMD	–	Standardised	mean	difference;	95%CI	-	95%	confidence	
interval;	Weight	-	weight	contributed	by	each	study	
	
Figure	3	SMD	for	fatigue	vs	active	comparators	
 
TE	-	Treatment	effect;	seTE	-	standard	error	of	the	TE;	SMD	–	Standardised	mean	difference;	95%CI	-	95%	confidence	
interval;	Weight	-	weight	contributed	by	each	study	
	
Figure	4	SMD	for	pain	vs	any	comparator	
 
TE	-	Treatment	effect;	seTE	-	standard	error	of	the	TE;	SMD	–	Standardised	mean	difference;	95%CI	-	95%	confidence	
interval;	Weight	-	weight	contributed	by	each	study	
	
	
3.3.2	Heterogeneity	and	publication	bias	
Using	the	I2	statistic,	heterogeneity	was	low	for	fatigue	(0%),	but	substantial	for	
pain	(77%).	The	funnel	plot	for	fatigue	identified	no	evidence	of	publication	bias	
(Figure	5).	The	p-value	from	Egger’s	Test	of	asymmetry	from	fatigue	studies	was	
0.256.			
	
Figure	5	-	Funnel	plot	for	fatigue	studies	
	
 
	
	
3.3.3	Outcomes	by	intervention	type	
Where	MBSR	was	used	(four	studies	26	32	34	35;	n=401),	SMD	for	fatigue	was	0.22	
(0.01	–	0.42),	p=0.04,	I2=0%;	for	pain	(two	studies	32	34)	SMD	was	-0.07	(-0.83	–	
0.68),	p=0.85,	I2=74%.	Outcomes	for	MBCT	came	from	a	single	pilot	study	30	
(n=40)	versus	usual	care,	where	effect	size	for	fatigue	was	0.29	(-0.18	–	0.76),	
p=0.30	and	the	effect	size	for	pain	was	0.59	(0.14	–	1.04),	p<0.05.	Compared	to	a	
psychoeducation	control,	a	study	using	Body-Affective	Mindfulness	(n=90)	33	had	
an	effect	size	of	0.19	(-0.22	–	0.60),	p=0.37	for	effect	on	fatigue.	
	
3.4	Study	quality	
Study	quality	was	highly	variable.	Assessment	was	frequently	made	challenging	
by	scanty	reporting.	For	unclear	reasons,	those	studies	of	highest	quality	(lowest	
RoB)	originated	from	European	countries	and	the	United	States.	Eight	studies	
outlined	random	sequence	generation	26	28-30	32-35.	Five	studies	were	adjudged	
low	risk	for	allocation	concealment	30	32-35,	with	the	remainder	unclear	26-29	31.	
Blinding	of	assessors	was	outlined	in	six	studies	29	30	32-35,	as	was	outcome	
assessor	blinding	29	30	32-35.	Five	studies	were	deemed	low	risk	when	assessing	
reporting	of	outcomes	as	incomplete	30	32-35.	One	study	was	assessed	as	at	high	
risk	for	selective	reporting	of	outcomes	31.	In	terms	of	overall	within	trials	RoB	
assessments,	five	studies	were	deemed	low	risk		30	32-35,	two	unclear	29,	and	three	
as	high	27	28	31.	Across	trials,	overall	RoB	was	low	for	random	sequence	allocation,	
unclear	for	allocation	concealment,	low	for	assessor	blinding,	low	for	blinding	of	
outcome	assessment,	unclear	for	incomplete	outcome	assessment,	low	for	
selective	outcome	reporting,	and	low	for	other	sources	of	bias.	Overall,	there	is	
an	unclear	RoB	across	trials.	(Table	4).	Appendix	C	details	rationale	for	RoB	
assessments.		
	
As	all	the	pain	studies	were	in	the	low	RoB	group,	Figure	6	illustrates	only	the	
SMD	for	all	trials	able	to	be	analysed	for	fatigue,	arranged	by	RoB	categories	
(low,	unclear	and	high).	Low	RoB	(n=5)	SMD	was	0.29	(0.09	–	0.49):	I2=0%	(low	
heterogeneity);	p<0.01.	Unclear	RoB	(n=1)	SMD	was	-0.01	(-0.37	–	0.35);	p=0.95.	
High	RoB	(n=1)	SMD	was	0.80	(-0.04	–	1.64);	p=0.06.	Effect	estimates	did	not	
vary	significantly	between	RoB	allocation	in	the	overall	RoB	analysis,	p=0.15.	
The	low	RoB	studies	are	most	likely	to	approximate	the	true	effect	of	an	MBI	on	
PwMS	who	have	fatigue,	with	(generally)	larger	sample	sizes,	a	higher	standard	
of	trial	procedures	and	hence	less	chance	of	inadvertent	bias.	
Table	4	–	Risk	of	Bias	
	
	 Mills	&	
Allen	
(2000)	
Grossmann	
et	al.	(2010)	
Bogosian	
et	al.	
(2015)	
Mahdavi	
et	al.	
(2016)	
Nejati	et	
al.	(2016)	
Simpson	
et	al.	
(2017)	
Carletto	
et	al.	
(2017)	
Cavelera	
et	al.	
(2018)	
Mosalanejad	
et	al.	(2018)	
Senders	
et	al.	
(2018)	
Across	
trials	–	
overall	
RoB	
Random	
sequence	
generation	
Unclear	 Low	 Low	 Unclear	 Low	 Low	 Low	 Low	 Low	 Low	 Low	
Allocation	
concealment	 Unclear	 Low	 Low	 Unclear	 Unclear	 Low	 Low	 Unclear	 Unclear	 Low	 Unclear	
Blinding	of	
assessors	 Unclear	 Low	 Low	 Unclear	 Unclear	 Low	 Low	 Unclear	 Low	 Low	 Low	
Blinding	of	
outcome	
assessment	
High	 Low	 Low	 Unclear	 Unclear	 Low	 Low	 Unclear	 Low	 Low	 Low	
Incomplete	
outcome	data	
addressed	
Unclear	 Low	 Low	 Unclear	 Unclear	 Low	 Low	 Unclear	 Unclear	 Low	 Unclear	
Selective	
outcome	
reporting	
High	 Low	 Low	 Low	 Low	 Low	 Low	 Low	 Low	 Low	 Low	
Other	sources	of	
bias	 Unclear	 Low	 Low	 High	 High	 Low	 Low	 Low	 Low	 Low	 Low	
Within	trials	
overall	RoB	 High	 Low	 Low	 High	 High	 Low	 Low	 Unclear	 Unclear	 Low	 Unclear	
Figure	6	Risk	of	Bias	Forest	plot	for	fatigue	studies
	
TE	-	Treatment	effect;	seTE	-	standard	error	of	the	TE;	SMD	–	Standardised	mean	difference;	95%CI	-	95%	confidence	
interval;	Weight	-	weight	contributed	by	each	study	
	
		
3.5	Adverse	events	
Two	studies	reported	on	adverse	events	associated	with	MBI	exposure	32	34.	In	
one	study	that	used	MBSR	a	participant	reported	an	episode	of	increased	
spasticity	during	mindful	body	awareness	34.	In	the	same	study	another	
participant	described	increased	anxiety	following	the	MBSR	retreat	34.	In	another	
study	using	MBSR	one	participant	with	chronic	pain	reported	increased	
symptoms	following	the	raisin	exercise	32.		
	
4.1	Discussion	
4.2	Summary	of	main	findings	
Ten	RCTs	that	assessed	the	effects	of	an	MBI	on	physical	symptom	outcomes	in	
PwMS	were	eligible	for	inclusion	in	our	systematic	review;	seven	of	these	had	
data	extractable	for	use	in	our	meta-analysis.	Four	studies	tested	an	MBI	against	
an	active	comparator,	four	tested	against	treatment	as	usual,	whilst	the	control	
condition	was	unclear	in	the	remaining	two	studies.	Intervention	fidelity	was	
reliably	assessed	in	only	one	study.	Sample	sizes	were	frequently	small.	Follow-
ups	took	place	from	immediately	post-MBI	to	up	to	1	year	following	course	
completion.		
	
Six	hundred	and	seventy-eight	PwMS	were	included	in	these	studies.	Most	(58%)	
had	relapsing	phenotypes.	Most	participants	were	female;	mostly	of	Caucasian	
ethnicity.	In	general,	comorbidity	and	disability	levels	were	poorly	reported.		
	
Four	studies	used	MBSR,	two	were	loosely	modeled	on	MBSR;	two	explicitly	used	
MBCT,	one	‘Mindfulness	of	Movement’,	and	in	one	case	the	basis	for	the	MBI	was	
unclear.	Most	interventions	were	provided	as	groups	(n=5-25),	delivering	core	
MBI	practices	in	and	between	sessions.	Level	of	teacher	training	and	experience	
were	not	well	reported.	MBI	session	attendance	+/-	home	practice	(treatment	
adherence)	was	described	in	six	studies.	Rates	of	attrition	varied	considerably	
(0-39%).	Although	very	few	adverse	events	were	described	from	MBI	training,	
few	studies	explicitly	reported	on	this	outcome.	
	
Five	RCTs	were	categorised	as	overall	low	RoB	using	the	Cochrane	Collaboration	
tool,	three	as	high	and	two	as	unclear,	signifying	an	overall	improvement	in	
study	quality	since	we	last	assessed	this	in	2014	14.			
	
Our	meta-analysis	indicates	that	MBIs	are	modestly	effective	treatments	for	
fatigue	in	PwMS,	but	evidence	to	support	improvements	in	pain	is	inconsistent.	
No	MBI	is	clearly	optimal	for	treating	impairment	of	fatigue	in	PwMS.	
	
4.3	Comparison	with	existing	literature	
In	this	study	we	found	MBIs	moderately	effective	for	improving	fatigue	(SMD	
0.24;	0.08	–	0.41),	but	inconsistent	with	regards	to	effects	on	pain	(SMD	0.16;	-
0.46	–	0.79)	in	PwMS.		
	
A	2018	meta-analysis	36	of	psychological	interventions	for	treating	fatigue	in	
PwMS	reported	CBT	to	be	moderately	effective	(SMD	0.32;	0.01	–	0.63)	and	MBIs	
to	be	considerably	more	effective	(SMD	0.62;	0.12	–	1.12),	but	only	included	two	
30	35	of	the	seven	26	28	30	32-35	RCTs	identified	in	our	current	review,	likely	
reflecting	an	earlier	search	cut-off	date	in	their	study	(April	2017).		
	
No	previous	meta-analysis	has	assessed	the	impact	of	MBI	training	on	pain	in	
PwMS,	but	in	chronic	pain	populations	at	large,	several	meta-analyses	have	been	
conducted.	A	2014	meta-analysis	37	reported	moderate	overall	treatment	effects	
(Cohen’s	d)	from	MBI	training	(0.33;	0.03	–	0.62),	a	finding	that	diminished	to	a	
null	effect	when	examining	the	effect	against	active	comparators.	A	2015	meta-
analysis	38	comprising	painful	musculoskeletal	conditions	reported	small	effects	
(Hedge’s	g)	versus	usual	care	following	MBI	training	on	pain	intensity	(0.16;	0.03	
–	0.36;	the	effect	attenuated	when	compared	against	active	comparators	to	0.09;	
-0.13	–	0.31),	moderate	effects	on	perceived	pain	control	(0.58;	0.23	–	0.93),	but	
larger	effects	on	pain	acceptance	versus	usual	care	(1.58;	-0.57	–	3.74).	Finally,	a	
2017	meta-analysis	39	found	small	overall	effects	against	any	comparator,	SMD	
0.32	(0.09	–	0.54),	but	included	a	wide	variety	of	clinical	syndromes.	
	
4.4	Strengths	of	this	review	
Guided	by	the	PRISMA	checklist	20,	the	TIDieR	checklist	18	and	the	Cochrane	
Collaboration	tool	19,	our	multidisciplinary	team	of	experienced	reviewers	used	
robust	search,	appraisal	and	analysis	techniques	for	extracting	and	analysing	
data	in	this	systematic	review	and	meta-analysis.	
	
4.5	Limitations	of	this	review	
Although	we	assessed	quality	using	a	reference	standard,	the	Cochrane	
Collaboration	RoB	tool,	we	did	not	estimate	the	strength	of	any	recommendation	
for	use	of	MBIs	in	PwMS.	Future	studies	could	do	so	by	applying	the	GRADE	
criteria	40.	
	
Meta-analyses	of	RCTs	by	design	exclude	other	potentially	relevant	data,	such	as	
that	deriving	from	observational	or	qualitative	research.	When	considering	
intervention	feasibility,	such	as	acceptability,	accessibility	and	implementability,	
these	alternate	study	designs	can	provide	important	insights	into	how	and	why	
interventions	succeed	or	fail	in	a	given	context.	However,	in	this	current	study,	
the	use	of	SPIO,	the	TIDieR	checklist	and	Cochrane	Collaboration	tool	for	RoB,	
means	that	our	evidence	synthesis	has	covered	other,	related	aspects	of	trial	
feasibility	and	execution.		
	
4.6	Strengths	and	Limitations	of	the	included	studies	
When	considering	the	strength	of	evidence	for	the	use	of	MBIs	in	PwMS,	most	
studies	which	assessed	impact	on	fatigue	(n=5/7)	and	all	that	assessed	impact	
on	pain	(n=3)	were	adjudged	low	RoB.	However,	despite	all	studies	being	RCTs,	
participant	numbers	were	low	(n=<50)	in	four.	Although	all	MS	phenotypes	were	
represented,	most	participants	had	relapsing-remitting	MS.	Furthermore,	mean	
sample	age	was	relatively	low	(46.0),	whilst	ethnicity,	SES	and	comorbidity	were	
poorly	covered,	limiting	the	generalisability	of	findings.	To	complicate	matters,	
several	studies	tailored	their	MBIs	with	minimal/absent	prior	justification.	Only	
four	compared	an	MBI	against	an	active	comparator	condition.	Observed	effects	
were	mostly	small,	with	a	wide	range	of	confidence	intervals.	Heterogeneity,	
overall,	was	low.		
	
Given	the	well	documented	high	levels	of	physical	comorbidity	in	PwMS,	it	is	
notable	that	our	meta-analysis	has	only	been	able	to	quantify	the	effects	of	MBI	
training	on	two,	albeit	common,	facets	of	physical	wellbeing,	namely	fatigue	and	
pain.	Other	aspects	of	physical	wellbeing	were	measured	in	individual	studies	
(e.g.	standing	balance,	sleep	and	sexual	function),	where	beneficial	effects	were	
reported,	but	meta-analysis	was	not	possible.	Future	studies	could	address	this	
evidence	gap	by	measuring	the	impact	of	MBI	training	on	other	common	physical	
symptoms	associated	with	MS,	for	example	dysarthria,	dysphagia,	bowel	and	
bladder	dysfunction,	dynamic	balance,	in-coordination	and	spasticity.	Although	
MBSR	and	MBCT	both	appear	to	be	effective	treatments	for	fatigue,	it	is	not	
currently	possible	to	recommend	one	approach	over	the	other.		
	
4.7	Implications	for	research	
The	quality	of	evidence	for	MBIs	as	effective	treatments	for	fatigue	in	PwMS	has	
improved	considerably	since	our	systematic	review	in	2014.	However,	
adherence	to	CONSORT	17	reporting	was	poor	in	several	studies	included	in	the	
meta-analysis,	with	three	studies	assessed	overall	as	high	risk	and	two	as	
unclear	according	to	the	Cochrane	Collaboration	19	tool.	In	addition,	MBI	
description	was	often	sparse	in	detail.	Were	researchers	to	adhere	more	closely	
to	the	CONSORT	17	and	TIDieR	18	checklists	when	reporting	studies	of	MBIs	for	
PwMS,	the	knowledge	base	in	this	area	could	be	further	enhanced,	helping	to	
clarify	where	further	research	efforts	should	focus.	
	
It	remains	unclear	which	type	of	MBI	may	be	best	for	PwMS	with	impaired	
physical	wellbeing	in	general,	or	fatigue	or	pain	more	specifically.	Future	
research	could	test	either	MBSR	or	MBCT	against	established	treatments	in	this	
area;	by	involving	people	affected	with	the	condition	in	this	endeavor,	the	co-
design,	delivery	and	ongoing	development	of	an	optimised	MBI	course	for	PwMS	
could	take	place	8.		
	
4.8	Implications	for	clinical	practice	
MBIs	appear	to	be	modestly	effective	at	improving	fatigue	in	PwMS.		
	
5.1	Conclusions	
Meta-analytic	evidence	supports	the	use	of	MBIs	in	PwMS	to	improve	fatigue.	
Evidence	to	support	the	use	of	MBIs	for	treating	pain	in	this	population	is	
inconsistent.	Although	the	quality	of	study	reporting	has	become	better,	room	
still	exists	for	enhanced	reporting	in	this	area.	No	clear	optimal	MBI	exists	for	
improving	impaired	physical	wellbeing	in	PwMS.		
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